NCT05698836 (CHAPTER) is a clinical trial in Premature Birth, sponsored by University of Oxford.

Who is sponsoring NCT05698836?

NCT05698836 is sponsored by University of Oxford.

What condition does NCT05698836 study?

NCT05698836 studies Premature Birth.

Is NCT05698836 still recruiting?

NCT05698836 is currently enrolling by invitation. Last updated 26 January 2023.

Last reviewed 2023-01-26 · How we verify

NCT05698836: CHAPTER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiovascular Health Assessment of Preterm- and TERm-born Children

ENROLLING BY INVITATION Last updated 26 January 2023

What this trial tests

trial in Premature Birth in 200 participants. Enrolling by invitation.

Timeline

21 March 2019

Primary endpoint
31 May 2023

1 June 2036

Quick facts

Lead sponsor	University of Oxford
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	200
Start date	21 March 2019
Primary completion	31 May 2023
Estimated completion	1 June 2036
Sites	1 location across United Kingdom

Conditions studied

Premature Birth — all drugs for Premature Birth →

Sponsor

University of Oxford

Who can join

Adults 3 to 9, any sex, with Premature Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the CHAPTER study is to help understand how complications during pregnancy, such as preterm birth, affect how childrens' hearts and blood vessels develop.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Premature Birth

Currently open trials in the same condition.

NCT07490912 — Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/o · recruiting
NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa · Phase 4 · recruiting
NCT06340971 — Air Pollution and Pregnancy · recruiting

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05698836 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 26 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05698836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing